| Title: |
Matching anticancer compounds and tumor cell lines by neural networks with ranking loss |
| Authors: |
Prasse, Paul; Iversen, Pascal; Lienhard, Matthias; Thedinga, Kristina; Bauer, Chris; Herwig, Ralf; Scheffer, Tobias |
| Contributors: |
German Federal Ministry of Research and Education |
| Source: |
NAR Genomics and Bioinformatics ; volume 4, issue 1 ; ISSN 2631-9268 |
| Publisher Information: |
Oxford University Press (OUP) |
| Publication Year: |
2022 |
| Description: |
Computational drug sensitivity models have the potential to improve therapeutic outcomes by identifying targeted drug components that are likely to achieve the highest efficacy for a cancer cell line at hand at a therapeutic dose. State of the art drug sensitivity models use regression techniques to predict the inhibitory concentration of a drug for a tumor cell line. This regression objective is not directly aligned with either of these principal goals of drug sensitivity models: We argue that drug sensitivity modeling should be seen as a ranking problem with an optimization criterion that quantifies a drug’s inhibitory capacity for the cancer cell line at hand relative to its toxicity for healthy cells. We derive an extension to the well-established drug sensitivity regression model PaccMann that employs a ranking loss and focuses on the ratio of inhibitory concentration and therapeutic dosage range. We find that the ranking extension significantly enhances the model’s capability to identify the most effective anticancer drugs for unseen tumor cell profiles based in on in-vitro data. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/nargab/lqab128 |
| Availability: |
https://doi.org/10.1093/nargab/lqab128; https://academic.oup.com/nargab/article-pdf/4/1/lqab128/43511024/lqab128.pdf |
| Rights: |
https://creativecommons.org/licenses/by-nc/4.0/ |
| Accession Number: |
edsbas.549477CC |
| Database: |
BASE |